Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Accuray Inc (NQ: ARAY )

4.980 USD -0.180 (-3.49%)
Official Closing Price Updated: 4:34 PM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Accuray Inc

< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Accuray Generated $55.6 Million in First Quarter Gross Orders; Revenue Increased 5 Percent Year over Year
Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first fiscal quarter ended September 30, 2017. 
From PR Newswire
European Court of Appeal Rejects Varian's Attempt to Reverse Customer Purchase of Accuray TomoTherapy® System
Accuray Incorporated (NASDAQ: ARAY) announced today that the Court of Appeal of Nantes has rejected the appeal filed by Varian Medical Systems opposing the purchase of the Accuray TomoTherapy® System... 
From PR Newswire
Accuray To Report Fiscal 2018 First Quarter Financial Results On October 24, 2017
Accuray Incorporated (NASDAQ: ARAY) will report results for its first quarter ended September 30, 2017 on Tuesday, October 24, 2017 after the market close. Management will host a conference call to... 
From PR Newswire
Accuray Incorporated Reports Inducement Grant Under NASDAQ Listing Rules
Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Stock Market Rules, an equity inducement award to Shig Hamamatsu, the company's new VP, Finance & Chief Accounting Officer. As... 
From PR Newswire
Today's Research Report Coverage on Medical Equipment Stocks -- CHF Solutions, ReWalk Robotics, Lantheus, and Accuray
From PR Newswire
10-year Data Shows CyberKnife® System Provides Excellent Long-term Control of Low-Risk Prostate Cancer
First Study to Evaluate the Use of Stereotactic Body Radiation Therapy in Low-Risk Prostate Cancer 10 Years Post Treatment 
From PR Newswire
Accuray Showcases CyberKnife® and Radixact™ Systems at ASTRO 2017
Accuray Incorporated (NASDAQ: ARAY) announced today that data and first-hand experience with its advanced CyberKnife® and Radixact™ Systems, and unique software solutions, will be shared by leading... 
From PR Newswire
Accuray Reports Fourth Quarter and Fiscal 2017 Financial Results
Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal year ended June 30, 2017. 
From PR Newswire
Medical Equipment Stocks on Investors' Radar -- Steris, Accuray, NuVasive, and NovoCure
From PR Newswire
Summit Cancer Center-Boise Treats Its First Cancer Patients Using the Accuray Radixact™ System
Freestanding Center is First in the Western U.S. to Treat Patients with this "Smart" Radiation Therapy Delivery System with Fully-Integrated Treatment Planning and Data Management Systems 
From PR Newswire
Accuray To Report Fiscal 2017 Fourth Quarter And Full Year Results On August 22, 2017
Accuray Incorporated (NASDAQ: ARAY) will report results for its fourth quarter and fiscal year 2017 ended June 30, 2017 on Tuesday, August 22, 2017 after the market close. Management will host a... 
From PR Newswire
First Radixact™ System Research Results Presented at the American Association of Physicists in Medicine Annual Meeting
Accuray Incorporated (NASDAQ: ARAY) announced today that the first studies validating the benefits of the leading-edge Radixact™ System were presented at the 59th Annual Meeting of the American... 
From PR Newswire
Accuray Receives 510(k) Clearance for iDMS™ Data Management System Upgrade for the TomoTherapy® System
iDMS System Allows Seamless Integration between Accuray Radixact™, TomoTherapy® and CyberKnife® Systems and Treatment Planning Systems 
From PR Newswire
Accuray Enhances Capital Structure Through Convertible Debt Transactions
­Transactions Facilitate Reduction of Short-term Debt and Potential Dilution to Shareholders 
From PR Newswire
Medical Equipment Stock Performance Review -- Amedica, Neovasc, Accuray, and NuVasive
From PR Newswire
New Data Show TomoTherapy® System Superior to RapidArc in Achieving Local Control of Head and Neck Cancers
Prospective, Multicenter Study Supported by the French National Institute of Cancer Also Demonstrates that Treatment with the TomoTherapy Platform Resulted in a Significantly Better Cancer-Specific... 
From PR Newswire
Accuray Announces Preliminary Fourth Quarter and Fiscal Year 2017 Results
Q4 Revenue Expected to be Approximately $111.5-$112 Million and Q4 Gross Orders Expected to be Approximately $86 Million; Accuray Expects to Finish Fiscal Year with Approximately $108 Million in Cash,... 
From PR Newswire
Neuro Spinal Hospital in Dubai to Acquire Accuray CyberKnife® and Radixact™ Systems
Leading Hospital will be the First in the Middle East to Offer Patients Precise Treatments with the Latest Generations of Both Systems 
From PR Newswire
Montefiore is First in NY Metropolitan Area to Treat Cancer Patients with Accuray Radixact™ System
Cutting-Edge Radiation Therapy System Dramatically Improves Precision, Efficiency and Safety, While Minimizing Side Effects 
From PR Newswire
IUCT Oncopole Advances Cancer Care in France with the New Accuray Radixact™ System
The French Cancer Institute is Building its Re-irradiation and Adaptive Radiotherapy Program Using the Latest Technology Developed by Accuray 
From PR Newswire
Anova Marks 1,500th Prostate Cancer Patient Treated with the Accuray CyberKnife® System
- Accuray and Anova Cancer Care Remember Prostate Patients this Father's Day 
From PR Newswire
Accuray Enters into New Revolving Loan Agreement
New Loan Expected to Reduce Interest Costs by Approximately $2.0 Million Annually 
From PR Newswire
Today's Research Report Coverage on Medical Equipment Stocks -- Neovasc, NuVasive, Amedica, and Accuray
From PR Newswire
Accuray Appoints Stan Gee VP of Revenue Management
Accuray Incorporated (NASDAQ: ARAY) announced today it has appointed, Stan Gee, who has been with Accuray for over eight years, to the newly created Vice President of Revenue Management position... 
From PR Newswire
New Data Reinforce Benefits of TomoTherapy® Platform for Mainstream Radiation Therapy Treatment Indications
Multiple Studies Presented at ESTRO 36 Demonstrate System Improves Tumor Control withReduced Toxicities 
From PR Newswire
New Data Presented at ESTRO 36 Reinforce Unmatched Versatility and Precision of the CyberKnife® System
Studies Show the System Provides Excellent Outcomes Throughout the Cancer Treatment Journey, from Primary Cases to Recurrence and Metastatic Disease 
From PR Newswire
Accuray to Showcase CyberKnife® and Radixact™ Systems at ESTRO 2017
Innovations in Hardware and Software Solutions Reinforce the Benefits of Accuray Systems in Treating a Wide Range of Cancer Cases 
From PR Newswire
CyberKnife® System Provides Effective Treatment Option with Minimal Side Effects and Excellent Cosmesis for Early Stage Breast Cancer Patients
Robotic Radiosurgery System's Unique Motion Management Technique Limits Toxicity and Preserves Cosmesis in Convenient, 5-Fraction Treatment Regimen 
From PR Newswire
Accuray Names Lionel Hadjadjeba Chief Commercial Officer
Chief Operating Officer Position Eliminated 
From PR Newswire
Accuray Third Quarter Gross Orders Increase 49% YoY; Backlog Up 21%
Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third fiscal quarter and nine months ended March 31, 2017. 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.